Select Publications

Journal articles

Clarke M; Mackay A; Ismer B; Pickles JC; Tatevossian RG; Newman S; Bale TA; Stoler I; Izquierdo E; Temelso S; Carvalho DM; Molinari V; Burford A; Howell L; Virasami A; Fairchild AR; Avery A; Chalker J; Kristiansen M; Haupfear K; Dalton JD; Orisme W; Wen J; Hubank M; Kurian KM; Rowe C; Maybury M; Crosier S; Knipstein J; Schüller U; Kordes U; Kram DE; Snuderl M; Bridges L; Martin AJ; Doey LJ; Al-Sarraj S; Chandler C; Zebian B; Cairns C; Natrajan R; Boult JKR; Robinson SP; Sill M; Dunkel IJ; Gilheeney SW; Rosenblum MK; Hughes D; Proszek PZ; Macdonald TJ; Preusser M; Haberler C; Slavc I; Packer R; Ng HK; Caspi S; Popović M; Faganel Kotnik B; Wood MD; Baird L; Davare MA; Solomon DA; Olsen TK; Brandal P; Farrell M; Cryan JB; Capra M; Karremann M; Schittenhelm J; Schuhmann MU; Ebinger M; Dinjens WNM; Kerl K; Hettmer S; Pietsch T; Andreiuolo F; Driever PH; Korshunov A; Hiddingh L; Worst BC; Sturm D; Zuckermann M; Witt O; Bloom T; Mitchell C; Miele E; Colafati GS; Diomedi-Camassei F; Bailey S; Moore AS; Hassall TEG; Lowis SP; Tsoli M; Cowley MJ; Ziegler DS; Karajannis MA; Aquilina K; Hargrave DR; Carceller F; Marshall LV, 2020, 'Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes', Cancer discovery, vol. 10, pp. 942 - 963, http://dx.doi.org/10.1158/2159-8290.CD-19-1030

Shen H; Yu M; Tsoli M; Chang C; Joshi S; Liu J; Ryall S; Chornenkyy Y; Siddaway R; Hawkins C; Ziegler DS, 2020, 'Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas', Neuro-Oncology, vol. 22, pp. 139 - 151, http://dx.doi.org/10.1093/neuonc/noz140

Franshaw L; Tsoli M; Lau LMS; Ziegler DS, 2019, 'Translating palbociclib to the clinic for DIPG - What is truly achievable?', EBioMedicine, vol. 45, pp. 22, http://dx.doi.org/10.1016/j.ebiom.2019.06.024

Rampersaud E; Ziegler DS; Iacobucci I; Payne-Turner D; Churchman ML; Schrader KA; Joseph V; Offit K; Tucker K; Sutton R; Warby M; Chenevix-Trench G; Huntsman DG; Tsoli M; Scott Mead R; Qu C; Leventaki V; Wu G; Mullighan CG, 2019, 'Germline deletion of ETV6 in familial acute lymphoblastic leukemia', Blood Advances, vol. 3, pp. 1039 - 1046, http://dx.doi.org/10.1182/bloodadvances.2018030635

Tsoli M; Shen H; Mayoh C; Franshaw L; Ehteda A; Upton D; Carvalho D; Vinci M; Meel MH; van Vuurden D; Plessier A; Castel D; Drissi R; Farrell M; Cryan J; Crimmins D; Caird J; Pears J; Francis S; Ludlow LEA; Carai A; Mastronuzzi A; Liu B; Hansford J; Gottardo NG; Hassall T; Kirby M; Fouladi M; Hawkins C; Monje M; Grill J; Jones C; Hulleman E; Ziegler DS, 2019, 'Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma (Journal of Neuro-Oncology, (2019), 141, 2, (253-263), 10.1007/s11060-018-03038-2)', Journal of Neuro-Oncology, vol. 141, pp. 265, http://dx.doi.org/10.1007/s11060-018-03060-4

Tsoli M; Shen H; Mayoh C; Franshaw L; Ehteda A; Upton D; Carvalho D; Vinci M; Meel MH; van Vuurden D; Plessier A; Castel D; Drissi R; Farrell M; Cryan J; Crimmins D; Caird J; Pears J; Francis S; Ludlow LEA; Carai A; Mastronuzzi A; Liu B; Hansford J; Gottardo N; Hassall T; Kirby M; Fouladi M; Hawkins C; Monje M; Grill J; Jones C; Hulleman E; Ziegler DS, 2019, 'International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma', Journal of Neuro-Oncology, vol. 141, pp. 253 - 263, http://dx.doi.org/10.1007/s11060-018-03038-2

Franshaw L; Tsoli M; Byrne J; Mayoh C; Sivarajasingam S; Norris M; Marshall GM; Ziegler DS, 2019, 'Predictors of Success of Phase II Pediatric Oncology Clinical Trials', Oncologist, vol. 24, pp. e765 - e774, http://dx.doi.org/10.1634/theoncologist.2017-0666

Tsoli M; Wadham C; Pinese M; Failes T; Joshi S; Mould E; Yin JX; Gayevskiy V; Kumar A; Kaplan W; Ekert PG; Saletta F; Franshaw L; Liu J; Gifford A; Weber MA; Rodriguez M; Cohn RJ; Arndt G; Tyrrell V; Haber M; Trahair T; Marshall GM; McDonald K; Cowley MJ; Ziegler DS, 2018, 'Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer', Cancer Biology and Therapy, vol. 19, pp. 1078 - 1087, http://dx.doi.org/10.1080/15384047.2018.1491498

Ziegler DS; Wong M; Mayoh C; Kumar A; Tsoli M; Mould E; Tyrrell V; Khuong-Quang DA; Pinese M; Gayevskiy V; Cohn RJ; Lau LMS; Reynolds M; Cox MC; Gifford A; Rodriguez M; Cowley MJ; Ekert PG; Marshall GM; Haber M, 2018, 'Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma', British Journal of Cancer, vol. 119, pp. 693 - 696, http://dx.doi.org/10.1038/s41416-018-0251-2

Tsoli M; Liu J; Franshaw L; Shen H; Cheng C; Jung MS; Joshi S; Ehteda A; Khan A; Montero-Carcabosso A; Dilda PJ; Hogg P; Ziegler DS, 2018, 'Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma', Oncotarget, vol. 9, pp. 7541 - 7556, http://dx.doi.org/10.18632/oncotarget.24045

Lapin DH; Tsoli M; Ziegler DS, 2017, 'Genomic insights into diffuse intrinsic pontine glioma', Frontiers in Oncology, vol. 7, http://dx.doi.org/10.3389/fonc.2017.00057

Hennika T; Hu G; Olaciregui NG; Barton KL; Ehteda A; Chitranjan A; Chang C; Gifford AJ; Tsoli M; Ziegler DS; Carcaboso AM; Becher OJ, 2017, 'Pre-clinical study of panobinostat in xenograft and genetically engineered murine diffuse intrinsic pontine glioma models', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0169485

Tsoli M; Swarbrick MM; Robertson GR, 2016, 'Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia', Seminars in Cell and Developmental Biology, vol. 54, pp. 68 - 81, http://dx.doi.org/10.1016/j.semcdb.2015.10.039

Vanniasinghe A, 2014, 'Depletion of White Adipose Tissue in Cancer Cachexia Syndrome Is Associated with Inflammatory Signaling and Disrupted Circadian Regulation', PLoS One, vol. 9, http://dx.doi.org/10.1371/journal.pone.0092966

Petruzzelli M; Schweiger M; Schreiber R; Campos-Olivas R; Tsoli M; Allen J; Swarbrick M; Rose-John S; Rincon M; Robertson G; Zechner R; Wagner EF, 2014, 'A switch from white to brown fat increases energy expenditure in cancer-associated cachexia', Cell Metab, vol. 20, pp. 433 - 447, http://dx.doi.org/10.1016/j.cmet.2014.06.011

Tsoli M; Moore MM; Burg DW; Painter AB; Taylor R; Lockie SH; Turner N; Warren A; Cooney GJ; Oldfield BJ; Clark SJ; Robertson GR, 2012, 'Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in mice', Cancer Research, vol. 72, pp. 4372 - 4382, http://dx.doi.org/10.1158/0008-5472.CAN-11-3536

Tsoli M; Robertson GR, 2012, 'Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem', Trends in Endocrinology and Metabolism, vol. 24, pp. 174 - 183, http://dx.doi.org/10.1016/j.tem.2012.10.006

Shum A; Theodore M; Taylor R; Painter AB; Moore MM; Tsoli M; Tan TC; Clarke SJ; Robertson GR; Polly P, 2012, 'Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting', Aging, vol. 4, pp. 133 - 143, http://dx.doi.org/10.18632/aging.100436

Keating J; Tsoli M; Hallahan AR; Ingram WJ; Haber M; Ziegler DS, 2012, 'Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastoma', Molecular Cancer Therapeutics, vol. 11, pp. 2654 - 2663, http://dx.doi.org/10.1158/1535-7163.MCT-12-0352

Lee A; Chick JM; Kolarich D; Haynes PA; Robertson GR; Tsoli M; Jankova L; Clarke SJ; Packer NH; Baker MS, 2011, 'Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.', Molecular & cellular proteomics : MCP, vol. 10

Matic M; Corradin AP; Tsoli M; Clarke SJ; Polly P; Robertson GR, 2010, 'The alternatively spliced murine pregnane X receptor isoform, mPXR 171–211 exhibits a repressive action', International Journal of Biochemistry and Cell Biology, vol. 42, pp. 672 - 682, http://dx.doi.org/10.1016/j.biocel.2010.01.001

Matic M; Mahns A; Tsoli M; Corradin AP; Polly P; Robertson GR, 2007, 'Pregnane X Receptor: Promiscuous regulator of detoxification pathways', International Journal of Biochemistry and Cell Biology, vol. 39, pp. 478 - 483, http://dx.doi.org/10.1016/j.biocel.2006.08.017

Tsoli M; Kuhn H; Brandau W; Esche H; Schmid G, 2005, 'Cellular uptake and toxicity of Au55 clusters', Small, vol. 1, pp. 841 - 844, http://dx.doi.org/10.1002/smll.200500104

Tsoli M; Kuhn H; Schmid G, 2004, 'Molecular docking simulations of the interactions between DNA molecules and a gold cluster', Materials Research Society Symposium Proceedings, vol. EXS, pp. 417 - 423

Liu Y; Meyer-Zaika W; Franzka S; Schmid G; Tsoli M; Kuhn H, 2003, 'Gold-cluster degradation by the transition of B-DNA into A-DNA and the formation of nanowires', Angewandte Chemie - International Edition, vol. 42, pp. 2853 - 2857, http://dx.doi.org/10.1002/anie.200250235


Back to profile page